Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Emilie Vannaxay

Emilie Vannaxay

Contact information


emilie.vannaxay@ndm.ox.ac.uk

Emilie Vannaxay

DPhil Student

Antibody assay development for emerging pathogens

I am a DPhil student in Professor Dame Sarah Gilbert's group. My work focuses on developing, characterising and validating antibody assays for outbreak pathogens such as MERS, Nipah and Lassa virus to ensure they are fit for purpose in upcoming clinical trials. Currently, I am exploring early immune responses and correlates of protection to the ChAdOx1 NipahB vaccine.

Previously, I was working in the Coronavirus (COVID-19) serology Infection Survey, a project between the University of Oxford and the Office of National Statistics to study infection rates and immune responses of the participants, particularly to monitor the effects of vaccination on immunity. During that time, I worked with high-throughput screening platforms to detect antibodies in samples collected from blood draws.